Medical Beauty Cost Comparison: Taiwan vs US, Korea, Japan, and Singapore

Quick answer: Botox is cosmetic and never covered by insurance, so price is the main lever — and it varies sharply by country. In the US a single Botox area runs about US$400–650 (more with master injectors); Japan, Korea, Singapore, and Taiwan all price below that. This guide compares real Botox, filler, Picosure, Thermage, and Sculptra prices across all five markets, and shows at what spend a flight actually pays for itself.

Medical aesthetics is almost always paid out of pocket — Botox for wrinkles, fillers for volume, and lasers for pigmentation are classified as cosmetic, which means insurance does not cover them anywhere in the world. That makes price one of the few real levers patients have, and it is also why "where you get treated" has become a global decision instead of a neighborhood one.

This guide goes treatment-by-treatment across five markets — the United States, South Korea, Japan, Singapore, and Taiwan — using current clinic pricing data drawn from RealSelf surveys, published Tokyo association rates, Gangnam clinic menus, and Taipei tier-one provider price lists. The goal is not to declare one country the cheapest. It is to help you understand why prices differ, and at what spending level the math actually justifies a flight.

USA pricing baseline — what you pay in NYC, SF, LA

The United States sits at the top of the global price ladder for medical aesthetics, particularly in coastal metros. RealSelf's 2025 community pricing data and AAD member surveys show consistent ranges across NYC, San Francisco, and Los Angeles:

• Botox: $400-650 per area in NYC and SF, with master injectors charging $700+ per area on Upper East Side or Pacific Heights. By-unit pricing typically runs $14-22/unit, and a standard upper-face treatment uses 40-60 units.
• HA fillers (Juvederm, Restylane): $700-1,500 per cc, with premium products like Voluma or Volux pushing $1,200-1,800/cc.
• Picosure / Picoway: $400-700 per session, with packages of 5 sessions running $1,800-3,000.
• Thermage FLX: $2,500-4,000 for full face, $3,500-5,500 with eye and neck add-on.
• Sculptra: $700-1,200 per vial; a typical face protocol uses 2-4 vials over a series.
• RF microneedling (Morpheus8, Vivace): $800-1,500 per session, packages $2,500-4,500.
• Hydrafacial: $200-400 per session in metro markets.

USA pricing reflects three overlapping cost drivers: physician compensation (board-certified dermatologists in NYC/SF earn $500K+), commercial real estate (Upper East Side med-spa rent runs $200-400/sq ft), and aggressive marketing spend. None of these directly translate into clinical superiority — the same Allergan Botox vial costs the clinic roughly the same in Manhattan and Manila.

Korea pricing — Gangnam aesthetics market

Seoul, particularly the Gangnam district, runs one of the highest-volume aesthetics markets on earth. That volume drives down per-procedure pricing on locally manufactured products:

• Korean toxins (Innotox, Botulax, Nabota, Meditoxin): priced well under imported Allergan Botox in Gangnam, and lower still with first-visit promotions. These are KFDA-approved domestic brands, not imported Allergan Botox.
• Allergan Botox (imported): up to $400 per area — closer to Taiwan pricing but still below USA.
• HA fillers: $400-800/cc for Korean-brand fillers (Yvoire, Neuramis, Chaeum), $700-1,100/cc for imported Juvederm or Restylane.
• Picosure / Picocare: up to $500 per session, often bundled into 3-5 session packages.
• Thermage FLX: $1,800-2,800 — meaningfully cheaper than USA, slightly cheaper than Taiwan.
• Sculptra: $500-900 per vial.

What is "lost" at Korean prices is harder to quantify but real. Quality variance is wider — the same treatment name can mean very different things between a tier-one Apgujeong clinic and a high-throughput Gangnam street-level chain. Language barriers for non-Korean patients are significant; consent forms, treatment plans, and post-care instructions are often translated only by a sales coordinator. Reputation incidents involving counterfeit fillers and unlicensed practitioners have surfaced periodically in Korean media. None of this means Korea is dangerous — top-tier Seoul dermatologists are world-class — but it does mean the buyer has to do more diligence than they would in a more regulated, lower-volume market.

Japan pricing — Tokyo conservative + less discounting

Japan's aesthetic medicine market behaves differently from Korea's. Tokyo association guidelines and the conservative culture of Japanese clinic operations produce minimum-rate pricing structures that resist the discount-driven model common in Gangnam:

• Botox (Allergan, imported): up to $600 per area in central Tokyo.
• HA fillers: $600-1,200/cc, similar to lower-tier USA pricing.
• Picosure: up to $500 per session, with less aggressive package discounting than Korea.
• Thermage FLX: $2,200-3,500.
• Sculptra: $700-1,000 per vial.

Japanese clinics tend to operate on imported brand names, conservative dosing, and longer consultation times. Many Tokyo aesthetic dermatologists deliberately do not advertise prices below an association-recommended floor. The result is a market that is high-quality and high-trust but offers little of the savings that draw international patients to Korea or Taiwan.

Singapore — close to USA premium tier

Singapore's medical aesthetics market is regulated by the Ministry of Health under some of the strictest cosmetic-procedure rules in Asia. Combined with high real estate costs in Orchard and CBD clinic districts, this produces pricing that sits at 80-120% of NYC/SF levels:

• Botox: $350-600 per area.
• HA fillers: $800-1,400/cc.
• Picosure / Picoway: $400-700 per session.
• Thermage FLX: $2,800-4,200.
• Sculptra: $800-1,300 per vial.

Singapore's premium pricing comes with regulatory safety, English-language consent and care, and high physician-to-patient ratios. For Southeast Asian patients seeking USA-equivalent quality without flying to North America, it is a reasonable choice. For patients from the USA or Europe, it offers little cost arbitrage.

Taiwan pricing — value-quality positioning

Taiwan's medical aesthetics market is regulated by the TFDA under standards that closely mirror FDA requirements for device approval, drug importation, and clinic licensing. Physician training routes (board certification through the Taiwan Dermatological Association or Taiwan Society of Aesthetic Plastic Surgery) are rigorous. Yet pricing sits dramatically below USA, Singapore, and Japan, and modestly below or comparable to top-tier Korean clinics:

• Botox (Allergan or Galderma Dysport): US$350 per area at New Dawn Health (see packages).
• HA fillers (Juvederm, Restylane, Teosyal): NT$15,000-25,000/cc (USD $480-800).
• Picosure Pro: US$400 per session at New Dawn Health (see packages).
• Thermage FLX: NT$80,000-130,000 full face (USD $2,560-4,160) — close to USA absolute pricing, but typically with concierge-style consultation, longer in-clinic time, and English-speaking coordinators.
• Sculptra: NT$20,000-35,000 per vial (USD $640-1,120).
• RF microneedling (Sylfirm X, Genius RF): NT$15,000-30,000 per session (USD $480-960).
• Hydrafacial: US$135 per session at New Dawn Health (see packages).

Taiwan's positioning is "value-quality" rather than "cheapest." Imported brand-name products dominate the market. Top clinics like the providers featured on our New Dawn Health network use the same FDA/TFDA-approved devices found in Beverly Hills or Tokyo. The price difference comes from structural cost factors, not clinical compromise.

Treatment-by-treatment pricing — comprehensive table

Why prices differ — regulation, labor, real estate, volume

The five-market spread is not arbitrary. Four structural factors explain almost all of it:

Regulation. Taiwan's TFDA, Japan's PMDA, and Singapore's HSA all run device-approval processes comparable to the FDA. Korea's KFDA is rigorous but moves faster on domestic device and toxin approvals, which is why a Picocare or Innotox can be priced lower than imported equivalents — they did not carry the cost of a multi-year FDA submission. Stringent regulation does not raise consumer prices directly, but it shapes which products are available and how aggressively they can be discounted.

Labor. A board-certified dermatologist in Taipei earns roughly 30-50% of what their San Francisco counterpart takes home. Korean physician compensation in Gangnam is closer to Taipei than to USA. Japanese physicians earn well but operate in shorter clinic hours. Labor cost is the single largest input into per-treatment pricing.

Real estate. A 1,500 sq ft clinic in Da'an District Taipei rents for roughly NT$200,000-350,000/month (USD $6,400-11,200). The same footprint in Manhattan runs $35,000-60,000/month. Even Gangnam Seoul rents are higher than Taipei. Real estate flows directly into the per-procedure cost the clinic has to recover.

Volume. Korea performs more aesthetic procedures per capita than any other country on earth. That volume amortizes equipment and training costs across more treatments, which is the structural reason a Korean Picocare session can be priced well below a Beverly Hills Picosure at $700. Taiwan's domestic volume is healthy but smaller than Korea's; this is partly why Taiwan pricing sits between Korea and Japan rather than below both.

Cheaper isn't always better — Korea quality variance

Naïve price-shopping in Korea has produced a steady stream of cautionary stories — counterfeit filler from gray-market suppliers, results that look great on Instagram and very different in the mirror, post-procedure complications handled in a language the patient cannot read. None of this is universal. Top Apgujeong dermatologists deliver world-class results.

The honest framing is this: Korea has the widest quality variance of any major aesthetics market. The best is genuinely the best in the world. The worst is genuinely concerning. The buyer carries the burden of telling the difference, and that burden is much harder when you do not speak Korean and are basing your decision on Instagram before-after photos.

Taiwan's market is smaller and more uniform. The quality floor is higher because the regulatory and licensing system filters more aggressively before a clinic opens. The ceiling is comparable to Korea's top tier. For a buyer who wants a strong outcome with less downside risk and English-speaking support, Taiwan is the structurally lower-variance choice. We unpack this further in our guide to Taiwan as a medical-beauty destination.

Travel cost-offset math — when the trip pays itself back

The question that actually matters: at what spending level does flying to Taiwan pay for itself?

The pattern is clear. A single Botox visit does not justify a flight from anywhere — flying to Taiwan for one syringe of filler is an emotional decision, not a financial one. The math turns positive at the upper end of USA pricing, roughly $6,000 USA-equivalent and above, and widens from there. Combine that with a vacation, food, and time away, and many patients describe the trip as "free" once the savings cover the airfare.

For more on what to expect logistically, see our overview of Taiwan as a destination and the laser treatments traveler's guide.

Returning patient annual cycle — maintenance economics

The single most underappreciated economic argument for Taiwan-based aesthetics is the maintenance cycle. Botox lasts 3-4 months. HA fillers last 6-12 months. Picosure protocols are typically 4-6 sessions spaced 4-6 weeks apart, with annual touch-ups. Thermage and Sculptra are roughly annual.

For a patient running a serious aesthetic program — the kind that costs $8,000-15,000/year in NYC or SF — the calculus changes. One Taiwan trip a year at $2,600 in travel and lodging is the version the math reliably supports, and the treatment savings on a $10,000+ annual program cover it. A second trip pays back only for patients buying at the top of the US price range. The patient ends up with the same maintenance cadence, lower total spend, and a trip to a country with excellent food and convenient transit.

This is why our network providers see a meaningful number of returning international patients on roughly six-month rhythms. The first trip is usually exploratory. By the third visit, the patient has built a relationship with their physician, knows which products work for their face, and is running a program that is both better-coordinated and substantially cheaper than what they would have spent at home.

One more line item often overlooked: tax. USA medical aesthetics are not deductible because they are classified as cosmetic. In Taiwan, a 5% Tax Refund Scheme (TRS) applies to certain elective treatments at participating clinics for foreign passport holders — small but real, and worth asking about at booking. The deeper context on injectables specifically is covered in our Botox & fillers in Taiwan guide, and the services overview lists what is currently bookable through New Dawn Health.

The honest bottom line

Korea wins on raw price for high-volume injectables and is the right choice for a knowledgeable buyer who can evaluate clinic quality. Japan delivers premium quality at premium prices and is rarely the value play. Singapore matches USA pricing with regulatory parity. The USA itself is the most expensive option in almost every category and is justified mainly by convenience.

Taiwan's structural position is the value-quality balance most international patients are actually looking for: regulated like Singapore, priced closer to Korea, with English-speaking support and lower quality variance than Gangnam. Once a patient's annual aesthetics spend exceeds about $10,000, the case for an annual Taiwan trip becomes hard to argue against on math alone.

Sources & Further Reading

• USPSTF — U.S. Preventive Services Task Force recommendations
• American Cancer Society — Cancer Facts & Figures
• NCI SEER — Surveillance, Epidemiology, and End Results Program
• CDC — Cancer prevention & screening
• American Heart Association — heart attack risk
• American College of Cardiology — clinical guidelines